Pharmaceuticals

Cannabinoid Derived Pharmaceutical Market Size, Share & Trends Analysis Report By Product (Natural (Plant-derived), Synthetic Cannabinoid), By Molecule Type (Cannabinoid Receptor Type 1 (CB1), Cannabinoid Receptor Type 2 (CB2), Others), By Disease Indication, By Route Of Administration, By Application, By Formulation, By Cannabinoid  Type, By Region, And Segment Forecasts, 2025-2034

Cannabinoid Derived Pharmaceutical Market Size is valued at USD 12.6 Billion in 2024 and is predicted to reach USD 81.1 Billion by the year 2034 at an 20.8% CAGR during the forecast period for 2025-2034. Cannabinoids are naturally occurring compounds derived from the Cannabis sativa plant. In recent years, Cannabinoids/medical marijuana have witnessed increased attention due to its growing therapeutic applications in human medicine. ...

Report ID: 1042  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Therapy / Modality Type (mRNA-based Therapeutics, DNA / Plasmid DNA Therapeutics, siRNA (Small Interfering RNA), Antisense Oligonucleotides (ASOs), Gene Therapy Products, Others), By Service Type (Process Development & Optimization, Drug Product (Formulation, Fill & Finish), Analytical & Quality Control (QC) Services, Regulatory Support & Technology Transfer, Packaging & Fill–Finish Services), By Workflow Stage (Preclinical Development, Clinical Manufacturing (Phase I–III), Commercial-Scale Production), By End User, By Therapeutic Area, By Region and By Segments Forecasts, 2025-2034

Global Nucleic Acid Therapeutics CDMO Market Size is valued at USD 2,540.9 Million in 2024 and is predicted to reach USD 8,688.2 Million by the year 2034 at an 13.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: A robust pipeline of nucleic acid-based drugs and high levels of investment from pharmaceutical companies and venture capitalists are boosting the market. The development of nove...

Report ID: 1348  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 185

GMP Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Product (Viral Vectors, Plasmid DNA, Non-viral, Lipid/polymer, Electroporation, Nanoparticles, Others), By Type, By Manufacturing Type, By Therapeutic Area, By Application, By Region, And By Segment Forecasts, 2025-2034

Global GMP Plasmid DNA Manufacturing Market Size is valued at USD 212.1 Million in 2024 and is predicted to reach USD 512.1 Million by the year 2034 at a 9.3% CAGR during the forecast period for 2025-2034. Modern medicine heavily relies on plasmid DNA (PDNA). Plasmid DNA can be utilized either explicitly for a variety of therapeutic purposes, including gene therapy and the production of vaccine antigens, or indirectly for a broad range of rese...

Report ID: 1437  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Preclinical Oncology Models Market Size, Share & Trends Analysis Report By Product (Neuroblastoma, Prostate Cancer, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Skin Cancer, Others), By Application, By Model Host Species, By Region, And Segment Forecasts, 2025-2034

Global Preclinical Oncology Models Market is valued at USD 1335.7 Million in 2024 and is predicted to reach USD 3733.0 Million by 2034, at a 10.9% CAGR during the forecast period 2025-2034. The rise of immuno-oncology therapy such as T cell therapy, bispecific antibodies, immune checkpoint modulators, and personalized cancer vaccines compels the need for unique preclinical and translational service solution. Recently advances in Immuno-oncolog...

Report ID: 1093  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Cell and Gene Therapy Supply Chain/Logistics Market Size, Share & Trends Analysis Report By Application area, By Type of software solution, By Mode of Deployment, By End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization) , By Scale of Operation, By Region, And By Segment Forecasts, 2025-2034

Cell and Gene Therapy Supply Chain/Logistics Market Size is valued at 1.5 Billion in 2024 and is predicted to reach 4.4 Billion by the year 2034 at a 11.9 % CAGR during the forecast period for 2025-2034. Global Cell and Gene Therapy Supply Chain/Logistics provides customizable services to support any stage of the supply chain, from the point of patient identification through cell harvest, therapeutic intervention, and long-term outcomes data c...

Report ID: 1694  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

In-Silico Drug Discovery Market Size, Share & Trends Analysis Report By Products (Software, Software-as-a-Service (SaaS), Consultancy-as-a-Service), By Workflow (Discovery, Pre-Clinical Tests, Clinical Trials), By Technology, By Software Type, By End User, By Region, And By Segment Forecasts, 2025-2034

Global In-Silico Drug Discovery Market Size is valued at USD 3.4 Billion in 2024 and is predicted to reach USD 12.8 Billion  by the year 2034 at a 14.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The growing emphasis on minimizing prescription errors, technological developments in computational biology, and the expanding usage of cloud-based technologies in drug discovery are dr...

Report ID: 2223  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Bevacizumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Abevmy, Alymsys, Avastin, Avzivi, Avzivi tnjn, Aybintio, Bambevi, Equidacent, Jobevne, Lextemy, Lytenava, Mvasi, Onbevzi, Oyavas, Vegzelma, Zirabev, and others (including products approved in developing countries and pipeline products), By Application, By Distribution Channel, Region And Segment Forecasts, 2025-2034

Global Bevacizumab Biosimilar Market is expected to grow at an 9.0% CAGR during the forecast period for 2025-2034. Bevacizumab is a recombinant humanized monoclonal antibody that neutralizes vascular endothelial growth factor A (VEGF-A) biologic activity (an essential endothelial cell mitogen and survival factor). It is the first anti-angiogenic therapy approved for the treatment of human cancer. The drug was developed by F. Hoffmann-La Roche AG...

Report ID: 1073  |  

Delivery: Immediate  |  

Published: October 2025   |  

No. of Pages: 170

Multi-Modal Spatial Omics Platforms Market, Share & Trends Analysis Report, By Multi-Omic Combination (RNA + Protein, Protein + Metabolite/Lipid, RNA + DNA / Genomic features, Tri-modal (RNA + Protein + Morphology/Metabolite)), By Detection Modality (In situ imaging (cyclic IF, fluorescence), In situ hybridization / in situ sequencing, ROI-based digital spatial profiling, Imaging mass cytometry/ion beam imaging, Barcoding-based spatial transcriptomics), By Workflow Component, By Sample Type, By Spatial Resolution, By Multiplexing Capacity, By Application, By End-User, By Region, and Segment Forecasts, 2025-2034

Multi-Modal Spatial Omics Platforms Market Size is valued at USD 174.23 Mn in 2024 and is predicted to reach USD 504.55Mn by the year 2034 at a 11.4% CAGR during the forecast period for 2025-2034. Multi-modal spatial omics platforms integrate multiple molecular layers—such as RNA, protein, and metabolites—within the same tissue section while preserving spatial context. By combining techniques like spatial transcriptomics, multiplex...

Report ID: 3243  |  

Delivery: Immediate  |  

Published: October 2025   |  

No. of Pages: 180

Electronic Investigator Site File (eISF) Market, Share & Trends Analysis Report, By Deployment Type (Cloud-Based, On-Premise), By End-User (Clinical Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Hospitals and Clinical Sites), By Application (Document Management, Regulatory Compliance, Collaboration Tools, Integration with eTMF/CTMS/EDC), By Component, By Trial Phase, By Region, and Segment Forecasts, 2025-2034

Electronic Investigator Site File (eISF) Market Size is predicted to grow at a 14.6 % CAGR during the forecast period for 2025-2034. The Electronic Investigator Site File (eISF) market is a rapidly evolving industry that provides digital alternatives to traditional paper-based Investigator Site Files (ISFs).  eISF platforms enable investigational sites to centrally manage essential study documents in a secure, real-time manner, while main...

Report ID: 3244  |  

Delivery: Immediate  |  

Published: October 2025   |  

No. of Pages: 180

Advanced Chromatographic Solutions for Biomolecules Market, Share & Trends Analysis Report, By Technology Type (Affinity Chromatography, Ion Exchange Chromatography (IEX), Mixed-Mode Chromatography, Size Exclusion Chromatography (SEC), Hydrophobic Interaction Chromatography (HIC), Membrane Chromatography, Monolithic Chromatography, Continuous Chromatography), By Product Type (Instruments, Consumables, Software & Services), By Application, By End-User By Region, and Segment Forecasts, 2025-2034

Global Advanced Chromatographic Solutions for Biomolecules Market Size is predicted to expand at a 9.7% CAGR during the forecast period for 2025-2034. Advanced chromatographic solutions refer to sophisticated techniques and technologies used for the separation, purification, and analysis of complex biomolecules, including proteins, peptides, nucleic acids, viral vectors, and monoclonal antibodies. These solutions play a critical role in biophar...

Report ID: 3246  |  

Delivery: Immediate  |  

Published: October 2025   |  

No. of Pages: 180

Categories